Advanced Medical Solutions Group (LON:AMS) Releases Quarterly Earnings Results

Advanced Medical Solutions Group (LON:AMS) posted its earnings results on Thursday. The company reported GBX 10.65 ($0.14) EPS for the quarter, Digital Look Earnings reports. Advanced Medical Solutions Group had a net margin of 8.49% and a return on equity of 4.57%.

Advanced Medical Solutions Group Trading Down 3.8 %

Advanced Medical Solutions Group stock opened at GBX 196.80 ($2.54) on Friday. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01. The stock has a market cap of £424.94 million, a PE ratio of 38.14, a P/E/G ratio of 5.00 and a beta of 0.74. The stock has a 50-day moving average price of GBX 211.70 and a 200 day moving average price of GBX 212.12. Advanced Medical Solutions Group has a 52 week low of GBX 176.60 ($2.28) and a 52 week high of GBX 275.83 ($3.56).

Advanced Medical Solutions Group Increases Dividend

The firm also recently announced a dividend, which will be paid on Friday, June 20th. Shareholders of record on Thursday, May 29th will be given a dividend of GBX 1.83 ($0.02) per share. The ex-dividend date is Thursday, May 29th. This represents a yield of 0.89%. This is a boost from Advanced Medical Solutions Group’s previous dividend of $0.77. Advanced Medical Solutions Group’s payout ratio is presently 38.76%.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank reissued a “buy” rating and set a GBX 300 ($3.87) price target on shares of Advanced Medical Solutions Group in a report on Wednesday.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.